Taghavi et al. worked with anti-MUC-1 aptamer (5TR1) and enhanced Epirubicin (Epi) drug released into MCF-7 breast cancer cells and CHO cells (hamster ovary cell line) [108]. The gene discussed is MUC1; the disease is breast carcinoma.